ERS Genomics Jun 28 New CRISPR/Cas9 license agreement for ERS Genomics and Cytosurge by ERS Genomics | June 28, 2022 1127 Dublin, Ireland | ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Cytosurge AG (‘Cytosurge‘). This is a non-exclusive licensing agreement granting Cytosurge access to ... Read more > Press Release Corporate FluidFM Applications Jun 28, 2022
Stony Brook University (SUNY) Jun 22 Research Centered on Single Cells May Open Doors to New Discoveries on Disease Processes by Stony Brook University (SUNY) | June 22, 2022 1087 Stony Brook, NY | Gábor Balázsi , PhD, and his research team in the Laufer Center and the Department of Biomedical Engineering at Stony Brook University are embarking upon a new way to research cells,... Read more > Press Release Corporate FluidFM Applications Jun 22, 2022
Claudia Frey Mar 30 Cytosurge launches cell line engineering services based on proprietary FluidFM® technology by Claudia Frey | March 30, 2022 1446 Zurich | Genetically engineered cell lines have become an invaluable tool in biological research and drug discovery. Nobel-prize winning CRISPR technology has opened up multiple opportunities for gene... Read more > Press Release Corporate FluidFM Applications Mar 30, 2022
Claudia Frey Jan 18 R&D project by Cytosurge and the Laboratory of Biosensors and Bioelectronics at the Swiss Federal Institute of Technology receives funding by Innosuisse by Claudia Frey | January 18, 2022 1415 Zurich | Cytosurge , a leading global provider for precision single cell manipulation, is delighted to announce that together with the Laboratory of Biosensors and Bioelectronics (LBB) at the Swiss Fe... Read more > Press Release Corporate FluidFM Applications Jan 18, 2022
Claudia Frey Mar 24 Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeks by Claudia Frey | March 24, 2021 1701 Zurich | Cytosurge , a leading global provider for precision single cell manipulation , announced today that its pioneering, patented FluidFM nano-probe enabled CRISPR multiplexing to generate monoclo... Read more > Press Release Corporate FluidFM Applications Mar 24, 2021
Claudia Frey May 04 Harvard's Wyss Institute joins forces with Cytosurge to improve CRISPR-based multiplexed gene editing by Claudia Frey | May 4, 2020 2618 Boston & Zurich | By Benjamin Boettner | Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Cytosurge AG , a company manufacturing unique high-precision nanotech... Read more > Press Release Corporate FluidFM Applications May 4, 2020
Claudia Frey Jul 14 FluidFM single cell extraction by Claudia Frey | July 14, 2016 1133 Zurich | A groundbreaking new method for single cell analysis based on FluidFM® technology allows scientist to investigate the behavior of individual cells within their natural environment. The new me... Read more > Press Release Corporate FluidFM Applications Jul 14, 2016
